title: What is the Role of the Bystander Response in Radionuclide Therapies?
abstract: Radionuclide therapy for cancer is undergoing a renaissance, with a wide range of radionuclide and clinical delivery systems currently under investigation. Dosimetry at the cellular and sub-cellular level is complex with inhomogeneity and incomplete targeting of all cells such that some tumor cells will receive little or no direct radiation energy. There is now sufficient preclinical evidence of a Bystander response which can modulate the biology of these un-irradiated cells with current research demonstrating both protective and inhibitory responses. Dependence upon fraction of irradiated cells has also been found and the presence of functional gap junctions appears to be import for several Bystander responses. The selection of either high or low LET radionuclides may be critical. While low LET radionuclides appear to have a Bystander response proportional to dose, the dose-response from high LET radionuclides are more complex. In media transfer experiments a "U" shaped response curve has been demonstrated for high LET treatments. However this "U" shaped response has not been seen with co-culture experiments and its relevance remains uncertain. For high LET treatments there is a suggestion that dose rate effects may also be important with inhibitory effects noted with 125I labelling study and a stimulatory seen with 123I labelling in one study.
authors: Centre for Cancer Research and Cell Biology, Queen's University Belfast , Belfast , UK.
authors: Darren
authors: D
authors: Brady
authors: Joe M
authors: JM
authors: O'Sullivan
authors: Kevin M
authors: KM
authors: Prise
keywords: Bystander effect; radioisotope; radionuclide; radiopharmaceuticals; targeted alpha therapy; targeted radionuclide therapy
references: Gene Ther. 2006 Jul;13(13):1052-6
references: 16525480
references: Radiat Res. 2001 Feb;155(2):335-44
references: 11175669
references: Int J Radiat Biol. 2012 Dec;88(12):1028-38
references: 22489958
references: Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13495-500
references: 15345742
references: Mol Pharmacol. 1984 Nov;26(3):539-46
references: 6493209
references: J Clin Oncol. 2002 May 15;20(10):2453-63
references: 12011122
references: Cytometry A. 2003 Dec;56(2):71-80
references: 14608634
references: Micron. 2002;33(2):127-32
references: 11567881
references: Int J Radiat Biol. 2012 Dec;88(12):1019-27
references: 22712702
references: Nat Rev Cancer. 2009 May;9(5):351-60
references: 19377507
references: Int J Radiat Biol. 1997 Apr;71(4):421-7
references: 9154145
references: Radiat Res. 2006 Jun;165(6):688-94
references: 16802869
references: Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13765-70
references: 12368480
references: Prostate Cancer Prostatic Dis. 2004;7(4):355-63
references: 15477875
references: Nucl Med Biol. 2013 May;40(4):471-80
references: 23522976
references: Cancer Res. 2005 Nov 1;65(21):9876-82
references: 16267011
references: Eur J Nucl Med Mol Imaging. 2008 May;35(5):1039-47
references: 18274745
references: J Clin Oncol. 2005 Feb 1;23(4):712-9
references: 15613695
references: Radiat Res. 2011 Aug;176(2):139-57
references: 21631286
references: Int J Radiat Biol. 2012 Jan;88(1-2):115-22
references: 21745001
references: J Pharm Pharmacol. 2008 Aug;60(8):951-8
references: 18644188
references: J Nucl Med. 2003 Dec;44(12):2019-26
references: 14660728
references: Cytometry A. 2004 Aug;60(2):155-64
references: 15290716
references: Thyroid. 2009 Nov;19(11):1167-214
references: 19860577
references: Cancer J. 2013 Jan-Feb;19(1):71-8
references: 23337760
references: Cytometry A. 2005 Jul;66(1):62-70
references: 15915508
references: J Nucl Med. 2007 Sep;48(9):1519-26
references: 17704246
references: Br J Cancer. 2013 Apr 16;108(7):1440-8
references: 23492685
references: Radiat Res. 2009 Jun;171(6):664-73
references: 19580473
references: Radiat Res. 1999 Jul;152(1):88-97
references: 10428683
references: Radiat Res. 1998 Nov;150(5):497-504
references: 9806590
references: J Nucl Med. 2010 Feb;51(2):311-28
references: 20080889
references: Cancer Res. 2007 Jun 15;67(12):5872-9
references: 17575156
references: Occup Med (Lond). 2006 May;56(3):156-61
references: 16641500
references: Radiat Environ Biophys. 2007 Nov;46(4):395-400
references: 17554548